Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication201220132014201520162017201820192020202120222023202420252026 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyProduct Development Unit Nov 2025 Antimicrob Resist Infect Control Strategies and challenges in containing antimicrobial resistance in East Africa: a focus on laboratory-based surveillance Autoren Molina A et al. Nov 2025 Eur Respir J Consensus on Management of Refractory Nontuberculous Mycobacterial Pulmonary Disease Autoren Moreira-Sousa D et al. Nov 2025 PLoS One Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection Autoren Weigl N et al. Nov 2025 Eur J Immunol Epigenetically Controlled ZEB2 Expression Promotes the Cytotoxic Potential of CMV-Specific CD8(+) T Cells Autoren Sasidharan Nair V et al. Nov 2025 Curr Top Microbiol Immunol Epstein-Barr Virus (EBV)-Specific Humoral Immune Responses in Health and Disease Autoren Mautner J Middeldorp JM Nov 2025 Eur J Immunol Origin of Hypofunctional CD103(+) NK Cells in Cirrhosis-Associated Ascites Autoren Niehaus C et al. Nov 2025 Cochrane Database Syst Rev Parallel use of low-complexity automated nucleic acid amplification tests on respiratory and stool samples with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children Autoren Olbrich L et al. Nov 2025 Philos Trans R Soc Lond B Biol Sci Quantitative measures of human Cytomegalovirus infection and their associations with tuberculosis disease progression and Mycobacterium tuberculosis infection Autoren Stockdale L et al. Nov 2025 Eur Respir J Safety of high dose bedaquiline treatment in extensively drug-resistant (XDR)-TB patients Autoren Peterka M et al. Nov 2025 Clin Immunol Compound heterozygous NFKB1 missense variants in cis associated with immunodeficiency Autoren Fliegauf M et al. Nov 2025 HIV Med Effective and safe use of immune checkpoint inhibitors for non-small cell lung cancer in people living with HIV Autoren Mispelbaum R et al. Nov 2025 J Biol Chem Elongator is required for pattern recognition receptor and type I interferon signaling in macrophages Autoren Murphy J et al. Nov 2025 Pathogens High Burden of Hepatitis B Virus and Occult Infection Among HIV-Positive Adults and Pregnant Women in Southwest Cameroon Autoren Mbencho MN et al. Nov 2025 Hepatology Commentary - AASLD Practice Guideline on treatment of chronic hepatitis B (2025 Update) Autoren Thompson AJ Cornberg M Nov 2025 PLoS One Two-stage cluster sampling to assess SARS-CoV-2 seroprevalence without pre-enumeration: An example from Madagascar Autoren Lorenz E et al. Nov 2025 Int J Infect Dis Diagnostic and therapeutic capacity for fungal infections in Colombia: An ESCMID-EFISG nationwide multicenter assessment of mycological healthcare Autoren Ceballos-Garzon A et al. Nov 2025 Emerg Microbes Infect Evidence for early circulation of the M1UK sublineage of Streptococcus pyogenes in Germany, 2015-2023 Autoren Rößler S et al. Nov 2025 Pneumologie [Treatment of Drug-Resistant Tuberculosis (DR-TB) in Germany, Austria and Switzerland - Updated Recommendations Based on the WHO Guidelines 2025] Autoren Lange C Schaberg T Otto-Knapp R Nov 2025 Angew Chem Int Ed Engl The Parkinson's Disease Drug Tolcapone and Analogues are Potent Glycomimetic Lectin Inhibitors of Pseudomonas aeruginosa LecA Autoren Leusmann S et al. Oct 2025 Int J Infect Dis A novel mechanism of unstable heteroresistance via reversible ompP2 mutations in Haemophilus influenzae Autoren Petersen S et al. Oct 2025 Infection Clinical and health economic impact of isavuconazole for treatment of invasive aspergillosis and mucormycosis: a retrospective, matched multicentre cohort study in Germany Autoren Engelhard M et al. Oct 2025 EBioMedicine Diagnostic accuracy of swab-based molecular tests for tuberculosis using near-point-of-care platforms: a multi-country evaluation Autoren Steadman A et al. Oct 2025 PLoS One Utilization of interdisciplinary in-hospital early rehabilitation in COVID-19 patients - a multicenter cohort study in the National Pandemic Cohort Network (NAPKON) in Germany Autoren Liebl ME et al. Oct 2025 Front Health Serv Acceptability and feasibility of a group intervention for long COVID in Johannesburg, South Africa: a mixed-method study Autoren Ramachandran R et al. Oct 2025 Trop Med Int Health Evaluation of Midwife-Led Colposcopy for Female Genital Schistosomiasis Screening at Primary Level of Care in Rural Madagascar: A Cross-Sectional Study Autoren Rausche P et al. Pagination Previous page ‹‹ Seite 3 Seite 4 Seite 5 Seite 6 Current page 7 Seite 8 Seite 9 Seite 10 Seite 11 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Seite 10 Seite 11 Next page ››
Nov 2025 Antimicrob Resist Infect Control Strategies and challenges in containing antimicrobial resistance in East Africa: a focus on laboratory-based surveillance Autoren Molina A et al.
Nov 2025 Eur Respir J Consensus on Management of Refractory Nontuberculous Mycobacterial Pulmonary Disease Autoren Moreira-Sousa D et al.
Nov 2025 PLoS One Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection Autoren Weigl N et al.
Nov 2025 Eur J Immunol Epigenetically Controlled ZEB2 Expression Promotes the Cytotoxic Potential of CMV-Specific CD8(+) T Cells Autoren Sasidharan Nair V et al.
Nov 2025 Curr Top Microbiol Immunol Epstein-Barr Virus (EBV)-Specific Humoral Immune Responses in Health and Disease Autoren Mautner J Middeldorp JM
Nov 2025 Eur J Immunol Origin of Hypofunctional CD103(+) NK Cells in Cirrhosis-Associated Ascites Autoren Niehaus C et al.
Nov 2025 Cochrane Database Syst Rev Parallel use of low-complexity automated nucleic acid amplification tests on respiratory and stool samples with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children Autoren Olbrich L et al.
Nov 2025 Philos Trans R Soc Lond B Biol Sci Quantitative measures of human Cytomegalovirus infection and their associations with tuberculosis disease progression and Mycobacterium tuberculosis infection Autoren Stockdale L et al.
Nov 2025 Eur Respir J Safety of high dose bedaquiline treatment in extensively drug-resistant (XDR)-TB patients Autoren Peterka M et al.
Nov 2025 Clin Immunol Compound heterozygous NFKB1 missense variants in cis associated with immunodeficiency Autoren Fliegauf M et al.
Nov 2025 HIV Med Effective and safe use of immune checkpoint inhibitors for non-small cell lung cancer in people living with HIV Autoren Mispelbaum R et al.
Nov 2025 J Biol Chem Elongator is required for pattern recognition receptor and type I interferon signaling in macrophages Autoren Murphy J et al.
Nov 2025 Pathogens High Burden of Hepatitis B Virus and Occult Infection Among HIV-Positive Adults and Pregnant Women in Southwest Cameroon Autoren Mbencho MN et al.
Nov 2025 Hepatology Commentary - AASLD Practice Guideline on treatment of chronic hepatitis B (2025 Update) Autoren Thompson AJ Cornberg M
Nov 2025 PLoS One Two-stage cluster sampling to assess SARS-CoV-2 seroprevalence without pre-enumeration: An example from Madagascar Autoren Lorenz E et al.
Nov 2025 Int J Infect Dis Diagnostic and therapeutic capacity for fungal infections in Colombia: An ESCMID-EFISG nationwide multicenter assessment of mycological healthcare Autoren Ceballos-Garzon A et al.
Nov 2025 Emerg Microbes Infect Evidence for early circulation of the M1UK sublineage of Streptococcus pyogenes in Germany, 2015-2023 Autoren Rößler S et al.
Nov 2025 Pneumologie [Treatment of Drug-Resistant Tuberculosis (DR-TB) in Germany, Austria and Switzerland - Updated Recommendations Based on the WHO Guidelines 2025] Autoren Lange C Schaberg T Otto-Knapp R
Nov 2025 Angew Chem Int Ed Engl The Parkinson's Disease Drug Tolcapone and Analogues are Potent Glycomimetic Lectin Inhibitors of Pseudomonas aeruginosa LecA Autoren Leusmann S et al.
Oct 2025 Int J Infect Dis A novel mechanism of unstable heteroresistance via reversible ompP2 mutations in Haemophilus influenzae Autoren Petersen S et al.
Oct 2025 Infection Clinical and health economic impact of isavuconazole for treatment of invasive aspergillosis and mucormycosis: a retrospective, matched multicentre cohort study in Germany Autoren Engelhard M et al.
Oct 2025 EBioMedicine Diagnostic accuracy of swab-based molecular tests for tuberculosis using near-point-of-care platforms: a multi-country evaluation Autoren Steadman A et al.
Oct 2025 PLoS One Utilization of interdisciplinary in-hospital early rehabilitation in COVID-19 patients - a multicenter cohort study in the National Pandemic Cohort Network (NAPKON) in Germany Autoren Liebl ME et al.
Oct 2025 Front Health Serv Acceptability and feasibility of a group intervention for long COVID in Johannesburg, South Africa: a mixed-method study Autoren Ramachandran R et al.
Oct 2025 Trop Med Int Health Evaluation of Midwife-Led Colposcopy for Female Genital Schistosomiasis Screening at Primary Level of Care in Rural Madagascar: A Cross-Sectional Study Autoren Rausche P et al.
